Bioactivity guided fractionation of leaves extract of Nyctanthes arbor tristis (Harshringar) against P falciparum

PLoS One. 2012;7(12):e51714. doi: 10.1371/journal.pone.0051714. Epub 2012 Dec 26.

Abstract

Background: Nyctanthes arbor-tristis (Harshringar, Night Jasmine) has been traditionally used in Ayurveda, Unani and other systems of medicine in India. The juice of its leaves has been used by various tribal populations of India in treatment of fevers resembling malaria.

Aim of the study: This work reports the antiplasmodial activity guided fractionation of Harshringar leaves extract.

Methodology: Crude ethanolic Harshringar leaves extract and its RPHPLC purified fractions were studied for antiplasmodial potency against 3D7 (CQ sensitive) and Dd2 (CQ resistant) strains of P.falciparum and subsequently subjected to bioassay guided fractionation using reverse phase chromatography to pursue the isolation of active fractions.

Principal findings: Harshringar crude leaves extract and some of its RPHPLC purified fractions exhibited promising antiplasmodial potency against 3D7 and Dd2 strains of P.falciparum.

Conclusions: The present study has provided scientific validity to the traditional use of leaves extract of Harshringar against malaria leading to the conclusion that this plant holds promise with respect to antimalarial phytotherapy. This is the first scientific report of antiplasmodial activity of RPHPLC fractions of Harshringar leaves extract against P.falciparum strains.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antimalarials / pharmacology*
  • Cells, Cultured
  • Chemical Fractionation
  • Erythrocytes / drug effects*
  • Erythrocytes / parasitology
  • Humans
  • India
  • Malaria, Falciparum / drug therapy*
  • Malaria, Falciparum / parasitology
  • Phytotherapy*
  • Plant Extracts / pharmacology*
  • Plant Leaves / chemistry*
  • Plasmodium falciparum / drug effects*
  • Spectrophotometry, Ultraviolet

Substances

  • Antimalarials
  • Plant Extracts

Grants and funding

This study was supported by Malaria Core Fund, ICGEB, New Delhi. All studies were conducted at ICGEB, New Delhi. Pinky Kumari got financial assistance from University Grants Commission, New Delhi, India in the form of “CSIR -UGC Research Fellowship, Award No - F.No.10-2(5)/2005(i)-E.U.II”. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.